| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 60.6 | 58.8 | 29.3 |
| Other income | 1.3 | 0.3 | 1.3 |
| Total income | 61.9 | 59.1 | 30.6 |
| Profit before exceptional items & tax | 1.1 | 2.4 | 1.9 |
| Profit before tax | 1.1 | 2.4 | 1.9 |
| Net profit | 0.9 | 1.6 | 1.5 |
| Operating margin | 1.8% | 4.1% | 6.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -40.00% |
|---|---|
| Net profit, quarter on quarter | -43.80% |
| Revenue, year on year | +106.80% |
Source
Read the filing ↗
NSE results filing, NSE: AJOONI. Figures extracted from the filing.
Ajooni Biotech Ltd: key numbers
- Share price
- ₹3.19
- Market cap
- ₹54.95 Cr
- Revenue (annual)
- ₹182.4 Cr
- Net profit (annual)
- ₹4.32 Cr
- P/E (TTM)
- 13.9×Sector 29.0×
- Promoter holding
- 26.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ajooni Biotech Ltd
All →
17:23 IST
NSE
Financial Results
Ajooni Biotech Q1 FY27 Results: Net Profit ₹0.4 Cr, Down 50.0% YoY
Ajooni Biotech Ltd reported revenue from operations of ₹63.5 Cr (+102.9% YoY) and net profit of ₹0.4 Cr (-50.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.4 Cr · -50.0% YoY